Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Rangering i aksjer #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Aksjekurs
$0.01292666
Sist synkronisert: 2025-04-08
Markedsverdi
$157.54K
Endring (1 dag)
6.84%
Endring (1 år)
0.00%
Land
GB
Handel Synairgen plc (SNG)

Kategori

Pris SNG pris med markedsverdi på B
Synairgen plc Synairgen plc
SNG
$0.01292666
Markedsverdi av Synairgen plc(SNG)
Markedsverdi: $157.54K
Per August 2026 har Synairgen plc en markedsverdi på $157.54K. Dette gjør Synairgen plc til det 40400th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Synairgen plc fra 2004 til 2026
SNG sammenlignet med topp 5 mest populære stocks
Pris på SNG Eiendel B Markedsverdi for B Resultater
Synairgen plc Synairgen plc
$448,790 $157.54K
$5.470T +3,471,815,955.71%
Synairgen plc Synairgen plc
$366,535 $157.54K
$4.467T +2,835,495,357.75%
Synairgen plc Synairgen plc
$342,519 $157.54K
$4.174T +2,649,712,215.36%
Synairgen plc Synairgen plc
$303,601 $157.54K
$3.700T +2,348,642,204.32%
Synairgen plc Synairgen plc
$234,206 $157.54K
$2.854T +1,811,807,993.27%